Philips has announced a move to expand its patient monitoring solutions, launching its IntelliVue platform with Masimo rainbow SET technology. The company will also let customers add rainbow SET to their existing IntelliVue monitors, and it’s working to integrate the technology into its SureSigns and Efficia patient monitoring platforms.
According to Philips, when combined with the appropriate monitoring platform Masimo rainbow SET technology analyzes multiple wavelengths of light tononinvasively and continuously measure patients’ total hemoglobin, oxygen content, carboxyhemoglobin, methemoglobin, and Pleth Variability Index. Continuous monitoring of total hemoglobin levels lets clinicians stay apprised of real-time changes in between invasive blood sampling.
To ensure that customers have a range of choices in SpO2 pulse oximetry measurement technology, Philips says it will continue to offer its FAST SpO2 pulse oximetry and Covidien’s OxiMax SpO2 pulse oximetry, depending on the patient monitoring platform.
For more information, visit the Philips website.